Hepatitis C virus infection and the prevalence of renal insufficiency

Lorien S Dalrymple1, Thomas Koepsell, Joshua Sampson

  • 1Health Services Research and Development Northwest Center of Excellence, Seattle, WA 98108, USA. dalrympl@u.washington.edu

Insights

Hepatitis C virus (HCV) infection is linked to a higher risk of kidney problems. This study found HCV-positive veterans had a significantly increased odds of renal insufficiency.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) is known to cause kidney damage.
  • The precise relationship between HCV and renal dysfunction requires further investigation.

Purpose of the Study:

  • To determine the prevalence of renal insufficiency in veterans with HCV.
  • To assess the association between HCV infection and the risk of developing renal insufficiency.

Main Methods:

  • Retrospective cohort study of 25,782 veterans tested for HCV antibodies between 1999-2004.
  • Renal insufficiency defined as creatinine ≥1.5 mg/dl.
  • Multivariate logistic regression used to analyze the association between HCV and renal insufficiency, adjusting for comorbidities.

Main Results:

  • HCV-positive veterans (4.8%) had a lower crude prevalence of renal insufficiency than HCV-negative veterans (6.0%).
  • After adjusting for age, race, gender, diabetes, and hypertension, HCV-positive veterans showed a 40% higher odds of renal insufficiency (OR 1.40; 95% CI 1.11-1.76).

Conclusions:

  • Hepatitis C virus infection is associated with an increased prevalence of renal insufficiency.
  • HCV may represent an independent risk factor for renal dysfunction in the veteran population.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...